Related Experiment Video
Updated: Jun 9, 2026

Transcutaneous Assessment of Renal Function in Conscious Rodents
Published on: March 26, 2016
Evaluating SCUBE-1 as Predictive Biomarker for Hypertension-Mediated Organ Damage: A Comparative Study
Betül Ayça Yamak1, Mustafa Candemir1, Emrullah Kızıltunç1
1Department of Cardiology, Gazi University Faculty of Medicine, 06560 Ankara, Turkey.
Insights
Serum signal peptide, CUB domain, and EGF-like domain-containing protein 1 (SCUBE-1) is elevated in hypertension patients with organ damage. Higher SCUBE-1 levels indicate greater hypertension-mediated organ damage (HMOD), suggesting its potential as a biomarker.
Area of Science:
- Cardiovascular Research
- Biomarker Discovery
- Hypertension Studies
Background:
- Hypertension-mediated organ damage (HMOD) is a major complication affecting cardiac, retinal, and renal systems.
- Serum signal peptide, CUB domain, and EGF-like domain-containing protein 1 (SCUBE-1) is a novel biomarker associated with vascular pathology.
- Investigating SCUBE-1's role in detecting HMOD is crucial for patient outcomes.
Purpose of the Study:
- To explore the relationship between SCUBE-1 levels and HMOD in hypertensive individuals.
- To assess the diagnostic utility of SCUBE-1 for detecting HMOD in hypertension.
Main Methods:
- A cross-sectional study involving 115 participants (79 hypertensive, 36 controls).
- Hypertensive patients were categorized based on the presence or absence of HMOD.
- SCUBE-1 levels were quantified and analyzed for diagnostic accuracy.
Main Results:
- Hypertensive patients showed significantly higher SCUBE-1 levels (160.70 ng/mL) than controls (75.64 ng/mL).
- Patients with HMOD exhibited markedly elevated SCUBE-1 levels (311.27 ng/mL) compared to those without HMOD (142.53 ng/mL).
- SCUBE-1 demonstrated significant diagnostic potential for cardiac (AUC 0.722), retinal (AUC 0.761), and renal (AUC 0.707) damage.
Conclusions:
- SCUBE-1 levels are significantly elevated in hypertensive patients, especially those with HMOD.
- SCUBE-1 shows promise as a valuable biomarker for predicting organ damage in hypertension.
- Further research can validate SCUBE-1 for clinical application in HMOD assessment.
Background:
Hypertension-mediated organ damage (HMOD) is a critical complication of hypertension that can present with cardiac, retinal, and renal manifestations and affect patient outcomes. Serum signal peptide, CUB (complement C1r/C1s, Uegf, and Bmp1) domain, and epidermal growth factor-like domain-containing protein 1 (SCUBE-1), a novel biomarker implicated in vascular pathology, shows promise for detecting HMOD. This study aims to explore the relation between SCUBE-1 levels and HMOD in hypertensive patients.
Methods:
This cross-sectional study included 115 participants, comprising 79 hypertensive patients and 36 healthy controls. The hypertensive patients were divided into two groups based on HMOD presence. SCUBE-1 levels were measured to evaluate their diagnostic utility in detecting HMOD.
Results:
Hypertensive patients exhibited significantly higher SCUBE-1 levels than controls (160.70 ng/mL vs. 75.64 ng/mL, p < 0.001). Among these patients, those with HMOD (cardiac, retinal, and renal) displayed even higher SCUBE-1 levels (311.27 ng/mL, range 137.86-460 ng/mL) compared to those without HMOD (142.53 ng/mL, range 110.56-178.19 ng/mL). Receiver operating characteristic curve analysis indicated that SCUBE-1 levels have significant diagnostic potential for differentiating between hypertensive patients with and without HMOD with area under the curve values of 0.722 for cardiac, 0.761 for retinal, and 0.707 for renal damage.
Conclusions:
Our study has revealed that SCUBE-1 levels are significantly elevated in hypertensive patients, particularly those with HMOD. The findings support the potential of SCUBE-1 as a valuable biomarker for predicting organ damage in hypertensive patients.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hypertension III: Clinical Manifestations and Diagnostic Studies

